These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 35802341)

  • 1. Inhaled nitric oxide for treating pain crises in people with sickle cell disease.
    Aboursheid T; Albaroudi O; Alahdab F
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD011808. PubMed ID: 35802341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled nitric oxide for treating pain crises in people with sickle cell disease.
    Aboursheid T; Albaroudi O; Alahdab F
    Cochrane Database Syst Rev; 2019 Oct; 10(10):CD011808. PubMed ID: 31603241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.
    Cooper TE; Hambleton IR; Ballas SK; Johnston BA; Wiffen PJ
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease.
    van Zuuren EJ; Fedorowicz Z
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD010155. PubMed ID: 26684281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnesium for treating sickle cell disease.
    Than NN; Soe HHK; Palaniappan SK; Abas AB; De Franceschi L
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011358. PubMed ID: 31498421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnesium for treating sickle cell disease.
    Than NN; Soe HHK; Palaniappan SK; Abas AB; De Franceschi L
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011358. PubMed ID: 28409830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate supplementation in people with sickle cell disease.
    Dixit R; Nettem S; Madan SS; Soe HHK; Abas AB; Vance LD; Stover PJ
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011130. PubMed ID: 29546732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D supplementation for sickle cell disease.
    Soe HH; Abas AB; Than NN; Ni H; Singh J; Said AR; Osunkwo I
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010858. PubMed ID: 28105733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions for chronic kidney disease in people with sickle cell disease.
    Roy NB; Carpenter A; Dale-Harris I; Dorée C; Estcourt LJ
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD012380. PubMed ID: 37539955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for treating neuropathic pain in people with sickle cell disease.
    Asnani MR; Francis DK; Brandow AM; Hammond Gabbadon CE; Ali A
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012943. PubMed ID: 31273755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate supplementation in people with sickle cell disease.
    Dixit R; Nettem S; Madan SS; Soe HH; Abas AB; Vance LD; Stover PJ
    Cochrane Database Syst Rev; 2016 Feb; 2():CD011130. PubMed ID: 26880182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative blood transfusions for sickle cell disease.
    Estcourt LJ; Kimber C; Trivella M; Doree C; Hopewell S
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003149. PubMed ID: 32614473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcutaneous electrical nerve stimulation (TENS) for pain management in sickle cell disease.
    Pal S; Dixit R; Moe S; Godinho MA; Abas AB; Ballas SK; Ram S; Yousuf UAM
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012762. PubMed ID: 32124977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.
    Smith S; Rowbotham NJ
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD001021. PubMed ID: 36373968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease.
    van Zuuren EJ; Fedorowicz Z
    Cochrane Database Syst Rev; 2013 Jun; (6):CD010155. PubMed ID: 23760785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for chronic kidney disease in people with sickle cell disease.
    Roy NB; Fortin PM; Bull KR; Doree C; Trivella M; Hopewell S; Estcourt LJ
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012380. PubMed ID: 28672087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics for people with cystic fibrosis.
    Coffey MJ; Garg M; Homaira N; Jaffe A; Ooi CY
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012949. PubMed ID: 31962375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidant supplementation for sickle cell disease.
    Bolarinwa AB; Oduwole O; Okebe J; Ogbenna AA; Otokiti OE; Olatinwo AT
    Cochrane Database Syst Rev; 2024 May; 5(5):CD013590. PubMed ID: 38775255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D supplementation for sickle cell disease.
    Soe HHK; Abas AB; Than NN; Ni H; Singh J; Said ARBM; Osunkwo I
    Cochrane Database Syst Rev; 2020 May; 5(5):CD010858. PubMed ID: 32462740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.